Don't forget to take a look at ETRM. I have 22k shares @ 1.195 avg cost and the FDA could set an expert advisory date anytime now; also the company has a CE mark in Europe for obesity and they are waiting on a decision to add additional CE marks for hypertension and diabetes.
I guess the theme is shoot the messenger dctrig and continue to stagnate with CYTK. At one time I was one of CYTK's biggest boosters, but the RS wised me up to quickly flip to ETRM. It's not too late to capture some money with ETRM and then flip back to CYTK, if so desired.